Surgery Partners Stock Performance
| SGRY Stock | USD 15.54 0.66 4.07% |
The entity has a beta of 0.2, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Surgery Partners' returns are expected to increase less than the market. However, during the bear market, the loss of holding Surgery Partners is expected to be smaller as well. At this point, Surgery Partners has a negative expected return of -0.48%. Please make sure to validate Surgery Partners' total risk alpha and day median price , to decide if Surgery Partners performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Surgery Partners has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return 0.37 | Five Day Return 4.11 | Year To Date Return 6.16 | Ten Year Return (1.70) | All Time Return (14.74) |
1 | Surgery Partners GAAP EPS of -0.18 misses by 0.27, revenue of 821.5M in-line | 11/10/2025 |
2 | Assessing Surgery Partners Valuation Following Fed-Driven Investor Optimism and Recent Share Price Rebound | 11/25/2025 |
3 | Surgery Partners, Inc. Announces Add-On Senior Notes Offering | 12/11/2025 |
4 | How the Narrative Surrounding Surgery Partners Is Shifting Amid Near Term Headwinds and Long Term Hopes | 12/12/2025 |
5 | Surgery Partners Issues 425M Senior Notes for Flexibility - TipRanks | 12/16/2025 |
6 | Surgery Partners Analyst Ratings Update Price Target Low - GuruFocus | 12/18/2025 |
7 | Mizuho Securities Reaffirm Bullish Stance on Surgery Partners | 12/22/2025 |
8 | Analysts Set Surgery Partners, Inc. Target Price at 27.11 | 12/31/2025 |
9 | RBC Capital and Mizuho Securities Stay Bullish on Surgery Partners | 01/09/2026 |
10 | Acquisition by Justin Oppenheimer of 77736 shares of Surgery Partners at 16.08 subject to Rule 16b-3 | 01/13/2026 |
11 | Surgery Partners stock jumps on takeover bid - MSN | 01/21/2026 |
| Begin Period Cash Flow | 195.9 M | |
| Total Cashflows From Investing Activities | -488.5 M |
Surgery Partners Relative Risk vs. Return Landscape
If you would invest 2,276 in Surgery Partners on October 29, 2025 and sell it today you would lose (656.00) from holding Surgery Partners or give up 28.82% of portfolio value over 90 days. Surgery Partners is currently does not generate positive expected returns and assumes 3.8332% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than Surgery, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Surgery Partners Target Price Odds to finish over Current Price
The tendency of Surgery Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 15.54 | 90 days | 15.54 | about 74.96 |
Based on a normal probability distribution, the odds of Surgery Partners to move above the current price in 90 days from now is about 74.96 (This Surgery Partners probability density function shows the probability of Surgery Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Surgery Partners has a beta of 0.2. This usually implies as returns on the market go up, Surgery Partners average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Surgery Partners will be expected to be much smaller as well. Additionally Surgery Partners has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Surgery Partners Price Density |
| Price |
Predictive Modules for Surgery Partners
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Surgery Partners. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Surgery Partners Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Surgery Partners is not an exception. The market had few large corrections towards the Surgery Partners' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Surgery Partners, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Surgery Partners within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.34 | |
β | Beta against Dow Jones | 0.20 | |
σ | Overall volatility | 2.57 | |
Ir | Information ratio | -0.11 |
Surgery Partners Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Surgery Partners for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Surgery Partners can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Surgery Partners generated a negative expected return over the last 90 days | |
| Surgery Partners has high historical volatility and very poor performance | |
| Surgery Partners has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Surgery Partners stock jumps on takeover bid - MSN |
Surgery Partners Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Surgery Stock often depends not only on the future outlook of the current and potential Surgery Partners' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Surgery Partners' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 126.1 M | |
| Cash And Short Term Investments | 269.5 M |
Surgery Partners Fundamentals Growth
Surgery Stock prices reflect investors' perceptions of the future prospects and financial health of Surgery Partners, and Surgery Partners fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Surgery Stock performance.
| Return On Equity | 0.0066 | ||||
| Return On Asset | 0.0419 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 5.76 B | ||||
| Shares Outstanding | 129.34 M | ||||
| Price To Earning | 61.84 X | ||||
| Price To Book | 1.21 X | ||||
| Price To Sales | 0.63 X | ||||
| Revenue | 3.11 B | ||||
| Gross Profit | 786.4 M | ||||
| EBITDA | 501.4 M | ||||
| Net Income | 12.5 M | ||||
| Cash And Equivalents | 227.4 M | ||||
| Cash Per Share | 2.58 X | ||||
| Total Debt | 3.7 B | ||||
| Debt To Equity | 1.44 % | ||||
| Current Ratio | 1.51 X | ||||
| Book Value Per Share | 13.50 X | ||||
| Cash Flow From Operations | 300.1 M | ||||
| Earnings Per Share | (1.36) X | ||||
| Market Capitalization | 2.09 B | ||||
| Total Asset | 7.89 B | ||||
| Retained Earnings | (737.3 M) | ||||
| Working Capital | 495 M | ||||
| Current Asset | 310.96 M | ||||
| Current Liabilities | 181.29 M | ||||
About Surgery Partners Performance
Evaluating Surgery Partners' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Surgery Partners has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Surgery Partners has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 15.67 | 16.24 | |
| Return On Tangible Assets | (0.05) | (0.06) | |
| Return On Capital Employed | 0.06 | 0.06 | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.11) | (0.10) |
Things to note about Surgery Partners performance evaluation
Checking the ongoing alerts about Surgery Partners for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Surgery Partners help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Surgery Partners generated a negative expected return over the last 90 days | |
| Surgery Partners has high historical volatility and very poor performance | |
| Surgery Partners has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Surgery Partners stock jumps on takeover bid - MSN |
- Analyzing Surgery Partners' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Surgery Partners' stock is overvalued or undervalued compared to its peers.
- Examining Surgery Partners' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Surgery Partners' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Surgery Partners' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Surgery Partners' stock. These opinions can provide insight into Surgery Partners' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.